Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01552369
What this trial is testing

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 205
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Post-approval studies (Phase 4)UnknownNCT02802280
What this trial is testing

Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents.

Who this might be right for
Hepatitis CCardiovascular Diseases
Instituto de Investigación Marqués de Valdecilla 80
Testing effectiveness (Phase 2)Study completedNCT01052480
What this trial is testing

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza

Who this might be right for
Influenza AInfluenza B
National Institute of Allergy and Infectious Diseases (NIAID) 98
Not applicableUnknownNCT05848427
What this trial is testing

The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19

Who this might be right for
COVID-19
Lebanese University 1,000
Testing effectiveness (Phase 2)UnknownNCT01529073
What this trial is testing

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Who this might be right for
HCV CoinfectionHIV Infection
Juan Macías 45
Testing effectiveness (Phase 2)Study completedNCT04724447
What this trial is testing

ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION

Who this might be right for
Major Depressive Disorder
Laureate Institute for Brain Research, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00663208
What this trial is testing

A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 167
Early research (Phase 1)Study completedNCT00801255
What this trial is testing

Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT01431898
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Gilead Sciences 82
Testing effectiveness (Phase 2)Ended earlyNCT04365101
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Who this might be right for
CoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more
Celularity Incorporated 7
Testing effectiveness (Phase 2)Study completedNCT03379675
What this trial is testing

Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 72
Testing effectiveness (Phase 2)Ended earlyNCT00305019
What this trial is testing

Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus

Who this might be right for
Hepatitis B
Bukwang Pharmaceutical 120
Post-approval studies (Phase 4)UnknownNCT02463019
What this trial is testing

Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis BAntiviral Treatment
E-DA Hospital 160
Not applicableStudy completedNCT02333292
What this trial is testing

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

Who this might be right for
Chronic Hepatitis C Infection
Valme University Hospital 1,128
Large-scale testing (Phase 3)Ended earlyNCT02606266
What this trial is testing

Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance

Who this might be right for
Congenital Cytomegalovirus (CMV)
Assistance Publique - Hôpitaux de Paris 1
Not applicableUnknownNCT03566030
What this trial is testing

Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance

Who this might be right for
Hepatitis BAntiviral Drug Adverse Reaction
Yonsei University 300
Not applicableUnknownNCT04470271
What this trial is testing

Re-linkage to Care of Patients With Hepatitis C

Who this might be right for
Viral Hepatitis C
Austral University, Argentina 1,000
Not applicableUnknownNCT04251572
What this trial is testing

HCV Reinfection After DAA Therapy in PWID in Belgium

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofDrug Use
Hasselt University 100
Next Page